Status:
RECRUITING
Cardiac Amyloidosis in HFpEF Tunisian Patients
Lead Sponsor:
University Tunis El Manar
Conditions:
Cardiac Amyloidosis
Heart Failure With Preserved Ejection Fraction
Eligibility:
All Genders
60-90 years
Brief Summary
Cardiac amyloidosis (CA) has recently been reported as a common cause of heart failure with preserved left ventricular ejection fraction (HFpEF), with a prevalence of 6% in elderly HFpEF patients. How...
Eligibility Criteria
Inclusion
- HFpEF during the previous year
- IVS thickness of 12mm or greater
Exclusion
- age under 60 years
- Acute coronary syndrome complicated by HFpEF
- Congenital heart disease
Key Trial Info
Start Date :
July 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
87 Patients enrolled
Trial Details
Trial ID
NCT06201832
Start Date
July 1 2023
End Date
December 31 2024
Last Update
January 17 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Security Hospital Forces
La Marsa, Tunis Governorate, Tunisia, 2070